Papillary Carcinoma Prognosis
Thyroid papillary carcinoma prognosis is the most common prognosis for thyroid cancer, happening between the ages of 30 and 50 years old. There are on average, 37,000 new thyroid cancer cases each year in the United States. Females are the gender that are most likely to have serous papillary carcinoma of thyroid. The ratio of women to men is three to one. Serous papillary carcinoma of thyroid can effect any age group of people, but most commonly peaks at ages 30 to 50 years old, and becomes it’s most aggressive in older patients. Most of patients who experience papillary renal cell carcinoma first notice a type of nodule on their thyroid that usually does not show any symptoms and patients should remember that over 99 percent of these nodules are not cancerous. But if cancer does appear in the thyroid it usually begins inside the nodule growing in the thyroid.
Occasionally symptoms of papillary renal cell carcinoma include neck pain, hoarseness, and enlarged lymph nodes. Seventy five percent of the population will have these thyroid nodules, and the majority will always be benign, meaning non cancerous. Young people, from birth to their twenties, will not have thyroid nodules, but as they age, again, it may occur. By the time the population is 80 year old, 90 percent of us will have at least one nodule.
People who are nervous about these nodules on their thyroids, far less than one percent of these nodules are malignant, meaning cancerous. If you get scans done on your thyroid nodules you will know when they are and are not cancerous, but the majority will be benign.
Uterine papillary serous carcinoma, and papillary renal cell carcinoma are both different types of thyroid cancers that can be treated like most cancers, by chemotherapy. Thyroid cancer is a very unique type of cancer, the cells in the body that are causing the cancer are completely different from other cancerous cells. Thyroid cancer cells are the only ones that have the ability to absorb iodine, and iodine is what is required to produce the thyroid hormone and get it out of the bloodstream. This makes chemotherapy the perfect solution to uterine papillary serous carcinoma and other thyroid cancers as well. Most all patients with thyroid cancer need radioactive iodine treatments after they receive surgery removing as many cells as can be removed. This important to know because after surgery iodine chemotherapy treatment is the only way to cure the rest of the cancerous cells in the thyroid.
This surgery does not have the same effect as most chemotherapy’s. It destroys the cells from within the body. There is no sickness, no hair loss no nausea, no diarrhea, and no pain associated with the therapeutic surgery.
These cancers listed above are often cured only by this chemotherapy iodine surgical treatment alone but it does vary from patient to patient and from cancer to cancer. The decision will always need to be mad between doctor and patient, and also referring to the endocrinologist or internist. The radioactive iodine therapy is a very safe and doctor recommended, so if you have a thyroid papillary carcinoma prognosis and if you need it, take it.
- Cancer Syndrome
- papillary carcinoma
- thyroid papillary carcinoma prognosis
- uterine papillary serous carcinoma